RxDoctor Payments Data

Holly Lewis, DO

Family Medicine · Lubbock, TXNPI 1376102624

Payments from drug & device makers

$1,396in general payments, 2019–2025

Across 71 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$198
  • Lilly USA, LLC$158
  • Pfizer$124
  • Takeda Pharmaceuticals U.S.A., Inc.$124
  • Astellas Pharma US Inc$120
  • AbbVie$114
  • plus $557 from 16 others

What the payments were for

  • Food & beverage$1,396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,396 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$82,701
Medicare patients
135
Services billed
2,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin62$84,391
OzempicSemaglutide67$73,749
MounjaroTirzepatide61$61,923
TrulicityDulaglutide36$49,756
FarxigaDapagliflozin Propanediol14$18,506
XareltoRivaroxaban23$17,730
EliquisApixaban16$14,105
JanuviaSitagliptin Phosphate12$10,153
VascepaIcosapent Ethyl13$4,508
Lidocaine17$2,669
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,283
Diclofenac Sodium20$2,115
Levothyroxine Sodium207$2,084
Gabapentin123$1,732
Atorvastatin Calcium208$1,398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$158$111,67897 claims
Novo NordiskOzempic$198$73,74967 claims
AstraZenecaFarxiga$43$18,50614 claims
PfizerEliquis$124$14,10516 claims
MerckJanuvia$21$10,15312 claims
AbbVieSynthroid$114$1,03218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →